Nature Communications (Mar 2021)

A haemagglutination test for rapid detection of antibodies to SARS-CoV-2

  • Alain Townsend,
  • Pramila Rijal,
  • Julie Xiao,
  • Tiong Kit Tan,
  • Kuan-Ying A. Huang,
  • Lisa Schimanski,
  • Jiandong Huo,
  • Nimesh Gupta,
  • Rolle Rahikainen,
  • Philippa C. Matthews,
  • Derrick Crook,
  • Sarah Hoosdally,
  • Susanna Dunachie,
  • Eleanor Barnes,
  • Teresa Street,
  • Christopher P. Conlon,
  • John Frater,
  • Carolina V. Arancibia-Cárcamo,
  • Justine Rudkin,
  • Nicole Stoesser,
  • Fredrik Karpe,
  • Matthew Neville,
  • Rutger Ploeg,
  • Marta Oliveira,
  • David J. Roberts,
  • Abigail A. Lamikanra,
  • Hoi Pat Tsang,
  • Abbie Bown,
  • Richard Vipond,
  • Alexander J. Mentzer,
  • Julian C. Knight,
  • Andrew J. Kwok,
  • Gavin R. Screaton,
  • Juthathip Mongkolsapaya,
  • Wanwisa Dejnirattisai,
  • Piyada Supasa,
  • Paul Klenerman,
  • Christina Dold,
  • J. Kenneth Baillie,
  • Shona C. Moore,
  • Peter J. M. Openshaw,
  • Malcolm G. Semple,
  • Lance C. W. Turtle,
  • Mark Ainsworth,
  • Alice Allcock,
  • Sally Beer,
  • Sagida Bibi,
  • Donal Skelly,
  • Lizzy Stafford,
  • Katie Jeffrey,
  • Denise O’Donnell,
  • Elizabeth Clutterbuck,
  • Alexis Espinosa,
  • Maria Mendoza,
  • Dominique Georgiou,
  • Teresa Lockett,
  • Jose Martinez,
  • Elena Perez,
  • Veronica Gallardo Sanchez,
  • Giuseppe Scozzafava,
  • Alberto Sobrinodiaz,
  • Hannah Thraves,
  • Etienne Joly

DOI
https://doi.org/10.1038/s41467-021-22045-y
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 12

Abstract

Read online

Serological detection of antibodies against SARS-CoV-2 can help establish rates of seroconversion. Here the authors develop a red cell agglutination test to detect antibodies against the receptor binding domain for distribution free of charge to qualified research groups.